The US FDA has cleared an investigational new drug (IND) application for HG202, by HuidaGene Therapeutics. This drug is the ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

Aerobic exercise has been linked with Parkinson's disease progression and risk. ( Washington Post) Air purifiers in residential aged-care facilities did not reduce the incidence of acute respiratory ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...

This drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related macular degeneration (nAMD). The US FDA has cleared an investigational new ...

AK132 is a bispecific antibody developed by Akeso, targeting the recombinant humanized Claudin18.2 (CLDN18.2) splice variant 2 and CD47 for the treatment of various cancers, including gastric, ...

A new drug application is planned for early 2025 for the indications ... results of p-value of less than 0.0001 for both doses tested. We expect to file an IND application for psoriasis with the FDA ...

At Intellia, we are ushering in [ph] a new era of medicine. During the third quarter and ... As announced this morning, the ...

The centralised procedure aims to reduce repeated local reviews of a study application. For investigational new drug (IND) studies, submission can be done via the JIRB or CIRB. The JIRB has been ...

Craig Morgan outlines why comparator clinical trials are useful and provides points to consider to ensure the best outcome. In clinical trials, a comparator drug (defined as ‘an investigational ...